Is heparin an acceptable anticoagulant when glycoprotein IIb/IIIa inhibitors are not used?

Michael S. Lee, Seung-Woon Rha, Kyung Woo Park, Moo Hyun Kim

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)223-224
Number of pages2
JournalJACC: Cardiovascular Interventions
Volume8
Issue number1
DOIs
Publication statusPublished - 2015 Jan 1

Keywords

  • Bivalirudin
  • Coronary artery disease
  • Heparin
  • Percutaneous coronary intervention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this